Research has shown that women with inherited mutations in the RAD51D gene have a heightened risk of developing ovarian cancer. This is because the impaired DNA repair mechanism allows for the accumulation of genetic errors, which can lead to cancerous transformations. Genetic testing for RAD51D mutations can help identify individuals at risk and guide preventive measures.
